Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Xing-Qian Yi"'
Autor:
Qing-Ying He, Xin-Yu Yu, Zheng Xiao, Xin Sun, Wei-Feng Zhu, Xing-Qian Yi, Qian Chen, Jia-Hui Zhang, Shu-Xian Chen, Xu Zhou, He-Yun Nie, Hong-Cai Shang, Xiao-Fan Chen
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Objectives: Danhong injections (DHI) are widely used in the treatment of acute myocardial infarction (AMI). As there are no guidelines for the timing of DHI in the peri-percutaneous coronary intervention (PCI) period for AMI, we investigated the effe
Externí odkaz:
https://doaj.org/article/e6fe6f395c974ed0951b91604d6454e5
Autor:
Jia-hui Zhang, Shu-xian Chen, Qinqin Yu, Rui-rong Zhang, Qian Chen, Xing-qian Yi, Xiao-Fan Chen, Jia-wei Dong, Hua Zhang, Qing-ying He
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3325dad7a813c9abbaff8df113a74d3
https://doi.org/10.37766/inplasy2021.6.0089
https://doi.org/10.37766/inplasy2021.6.0089
Autor:
Jia-hui Zhang, Hongcai Shang, Xing-qian Yi, Wei-Feng Zhu, Heyun Nie, Xiao-Fan Chen, Xu Zhou, Xin Sun, Xin-yu Yu, Zheng Xiao, Qian Chen, Qing-ying He, Shu-xian Chen
Publikováno v:
Frontiers in Pharmacology
Frontiers in Pharmacology, Vol 12 (2021)
Frontiers in Pharmacology, Vol 12 (2021)
Objectives: Danhong injections (DHI) are widely used in the treatment of acute myocardial infarction (AMI). As there are no guidelines for the timing of DHI in the peri-percutaneous coronary intervention (PCI) period for AMI, we investigated the effe